Featured
Last news
Rythmia Life Advancement Center Surpasses $1 Million in Scholarship Awards, Sending 156 Recipients to Medically Licensed Ayahuasca Retreat
Need-based program removes financial barriers to plant medicine healing, awarding over $1,008,105 in full retreat scholarships to date.
New Analysis Finds Global Drug Pricing Benchmarking May Fall Short on Affordability
WASHINGTON, D.C. / ACCESS Newswire / February 11, 2026 / A new report by Aimed Alliance, international patient advocates, and advocacy organizations, found that due to the United States' unique health care system, an international reference pricing program, such as those proposed under the Centers for Medicare and Medicaid Services (CMS) GUARD and GLOBE models, may not meaningfully improve affordability for consumers.
AMEEREX CORPORATION (OTC: HIRU) Issues Complementary Clarification to January 7, 2026, Press Release: ~US$66 Billion In-Situ Lithium Resource; Structured Dual Exposure
ATLANTA, GA and DOHA, QATAR / ACCESS Newswire / February 11, 2026 / Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company" provides this complementary clarification to its press release dated January 7, 2026, to ensure the market clearly understands the scale and structure of its lithium participation framework and updates the underlying lithium resource value based on current battery-grade lithium carbonate pricing.
Brenmiller Energy Executes on Technology Roadmap with Early Launch of bGen ONE(TM)
Advancing Cost Competitive Thermal Energy Storage by Cutting on Site Costs Through Factory Built Design
Gallardo Periodontics Highlights Early Steps to Prevent Gum Disease and Tooth Loss
Dr. John Paul Gallardo explains how recognizing early gum disease signs can support long-term oral and systemic health.
Organto Foods Inc. Expands Scalable and Flexible Logistics Platform to Support 2026 Growth
Logistics and infrastructure platform positioned to scale with increased commercial growth
Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements
ESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it has entered into a securities purchase agreement on February 6, 2026 (the "Securities Purchase Agreement") with select institutional and accredited investors (collectively, the "Investors") for the purchase and sale of up to 26,250 shares of Series A Convertible Preferred Stock (each, a "Preferred Share" and collectively, the "Preferred Shares"), at a purchase price of $800 per Preferred Share. The Preferred Shares are convertible into shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), representing aggregate gross proceeds to the Company of up to $21.0 million, before deducting placement agent fees and other offering expenses (the "Offering").
Black Book Research Releases "Brazil Acute Care EHR and Digital Health 2026" Report Highlighting RNDS Interoperability, AI Governance Readiness, and Cyber-Resilient Hospital Modernization
As part of the 700-page 2026 Black Book State of Global Digital Healthcare, this continuing series spotlights Brazil, one of the world's fastest-growing regions for EHR adoption and interoperability software.
Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion
Tollo Health recently formed subsidiary TolloCare, LLC ('TolloCare') initially targeted to provide telehealth services for GLP-1 and Long COVID patientsTolloCare has white-labeled telehealth capabilities via a telemedicine company with over 5,000 onboarded physicians nationwide to provide synchronous and asynchronous medical services, including prescriptions, for weight loss and separately will cultivate a Long COVD physician baseTollo Health has entered into agreement to expand TolloCare capabilities via a partnership with a stealth San Francisco Bay Area startup preparing to deploy a mental health AI app with unique tools to engage with patients
Genflow Biosciences PLC Announces Notice of GM
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Genflow Biosciences PlcNotice of General Meeting
YouTube says it is not social media in landmark addiction trial
A lawyer for YouTube insisted Tuesday that the Google-owned video platform was neither intentionally addictive nor technically social media, as a landmark US trial targeting tech giants entered its second day.
Colombian senator kidnapped, president targeted in election run-up
A Colombian senator was kidnapped and held hostage for hours Tuesday as the country's president reported an attempt on his own life in the run-up to elections that observers have warned could be marred by violence.
Gisele Pelicot publishes memoirs after rape trial ordeal
Gisele Pelicot, the survivor of mass rapes organised by her husband at their home in southern France, has published her memoirs about the trial that turned her into an internationally celebrated figure in the movement to end violence against women.
Venezuelan authorities move Machado ally to house arrest
A close ally of Venezuelan opposition leader Maria Corina Machado was placed under house arrest Tuesday, detained just hours after his release from prison along with other dissidents jailed under ousted leader Nicolas Maduro.
Paris officers accused of beating black producer to stand trial in November
Three police officers will stand trial in November for the 2020 beating of a black music producer in his Paris studio, sources close to the case told AFP on Tuesday.
Istanbul bars rock bands accused of 'satanism'
Istanbul authorities on Tuesday banned concerts by two foreign rock bands, Slaughter to Prevail and Behemoth, after Islamist commentators accused them of "satanism".
Mayor of Ecuador's biggest city arrested for money laundering
The mayor of Ecuador's violence-ravaged city of Guayaquil, a fierce critic of President Daniel Noboa, was arrested Tuesday along with the president of a top football club for alleged money laundering, prosecutors said.
Bangladesh's PM hopeful Rahman warns of 'huge' challenges ahead
Bangladesh's leading prime ministerial hopeful Tarique Rahman said on Tuesday he faces "huge" challenges if he wins elections this week, vowing to repair a country he said was looted under the previous ousted government.
Shock on Senegalese campus after student dies during police clashes
Senegal ordered the closure of student residences at a major university in Dakar on Tuesday, a day after a medical student died during clashes with police, shocking the university community.
US singer leaves talent agency after CEO named in Epstein files
US singer-songwriter Chappell Roan announced on Monday that she had left her talent agency, after its CEO was named in files related to late convicted sex offender Jeffrey Epstein.
Warming climate threatens Greenland's ancestral way of life
Standing in his boat with binoculars in hand, hunter Malik Kleist scans the horizon for seals. But this February, the sea ice in southwestern Greenland has yet to freeze, threatening traditional livelihoods like his.
New York seeks rights for beloved but illegal 'bodega cats'
Simba, a large cat with thick ginger and white fur, is one of thousands of felines that live in New York's corner shops known as "bodegas" -- even if their presence is illegal.
Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type A meeting to understand the path forwardmRNA-1010 has been submitted and accepted for review in the EU, Canada and AustraliaCompany does not expect any impact on its 2026 financial guidance
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for both the three months and nine months ended December 31, 2025EBITDAS loss decreased by $0.4 million and $0.9 million for the three and nine months ended December 31, 2025 compared to prior year
David's Bridal Unveils Soft Romance, the Second Capsule in Its Spring 2026 Collection Series
The Limited-Edition Drop Channels the Feminine Revival Through Romance, Dreamlike Movement, and Elevated Softness
Jorie AI Shares a Live Case Study on the Inevitable Future of Healthcare AI at ViVE 2026
Demonstrating what it takes for healthcare AI to work end to end
Leading Board-Certified Plastic Surgeon Dr. David W. Allison Moves to New Princeton Location on Bunn Drive
Experienced plastic surgeon relocates to Princeton, offering face, breast, body, and reconstructive procedures.
CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
The following amendment has been made to the Issue of Equity' announcement released on 10 February 2026.The sentence "through a direct subscription for 313,333 new ordinary shares in the Company at a price of £7.50 per share" has been corrected to "through a direct subscription for 333,333 new ordinary shares in the Company at a price of £7.50 per share." And the sentence "the enlarged issued share capital of the Company will comprise 6,354,588 ordinary shares" has been corrected to "the enlarged issued share capital of the Company will comprise 6,374,588 ordinary shares."All other details remain unchanged.The full amended text is shown below.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Hemogenyx Secures £2,500,000 to continue its Phase 1 Clinical TrialsIntroduction
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
LONDON, UK / ACCESS Newswire / February 10, 2026 / Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases, switching your dog to a more sustainable diet may have a bigger impact on the planet and farmed animals than changing your own diet.
MDCE Turns $1M Asset Portfolio Into Strategic Capital for AI Development (OTC PINK:MDCE)
MESA, AZ / ACCESS Newswire / February 10, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced it is executing a non-dilutive funding strategy supported by tangible, high-value assets held by its wholly owned subsidiary, Infinite Auctions, which currently maintains an estimated market value approaching $1 million in sports cards and elite game-worn memorabilia. This is exciting news with the pending release of the company's first AI based mobile application.
TRNR Files Lawsuits Against Sportstech and Ali Ahmad and Announces March 11, 2026 Public Auction of All Shares of Sportstech
Company initiates legal proceedings to enforce defaulted loan and personal guaranteeFormal auction proceedings also initiated under German Civil Code with a public auction notice for March 11
Cheech and Chong's Cannabis Company Expands Retail Tech Stack With Flowhub Partnership
New Integration Strengthens the Cheech and Chong Partner Network, Giving Independent Dispensaries the Tools to Compete and Win